C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/04/2004	WO2004094663A2 Method for identifying characteristics of molecules by converting said characteristics into a polynucleotide sequence
11/04/2004	WO2004094662A2 Method of preparing dna fragments by selective fragmentation of nucleic acids and applications thereof
11/04/2004	WO2004094661A2 Fancc, dad1, grim19 and hadhii marker genes of psoriasis
11/04/2004	WO2004094660A2 Use of gene dpysl3 as a marker of psoriasis
11/04/2004	WO2004094659A1 Associations of polymorphisms in the frzb gene with obesity and osteoporosis
11/04/2004	WO2004094658A2 Fluorescent substrates for detecting organophosphatase enzyme activity
11/04/2004	WO2004094657A1 Apparatus and method for testing liquid samples
11/04/2004	WO2004094656A1 Assay for detecting mycoplasma by measuring acetate kinase or carbama kinase activity
11/04/2004	WO2004094655A2 Modulation of telomere-initiated cell signaling
11/04/2004	WO2004094654A2 Transfection kinetics and structural promoters
11/04/2004	WO2004094653A2 Differential tag length analysis of cell proliferation
11/04/2004	WO2004094641A2 A novel method of modulating bone-realted activity
11/04/2004	WO2004094638A1 Vasculitis antigen and method of diagnosing vasculitis
11/04/2004	WO2004094632A1 Method of detecting histamine-producing bacterium and primer for use in the method
11/04/2004	WO2004094628A1 Imanitib-resistant philadelphia chromosome-positive human acute lymphocytic leukemic cell line and utilization thereof
11/04/2004	WO2004094617A2 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094608A2 Human procolipase like nucleic acids and polypeptides and their methods of use threof
11/04/2004	WO2004094606A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
11/04/2004	WO2004094602A2 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
11/04/2004	WO2004094595A2 MODIFIED iRNA AGENTS
11/04/2004	WO2004094593A2 Expanding the eukaryotic genetic code
11/04/2004	WO2004094470A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases
11/04/2004	WO2004094456A2 Immuno-amplification
11/04/2004	WO2004094455A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	WO2004094027A2 Microfiltration and/or ultrafiltration process for recovery of target molecules from polydisperse liquids
11/04/2004	WO2004094020A2 Crystal growth devices and systems, and methods for using same
11/04/2004	WO2004093925A1 High throughput biological indicator reader technical filed
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093909A1 Methods to regulate biofilm formation
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093784A2 Systems and methods for blood glucose sensing
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	WO2004093646A2 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/04/2004	WO2004093645A2 Tn5 transposase mutants and the use thereof
11/04/2004	WO2004093644A2 Methods and apparatus for genetic evaluation
11/04/2004	WO2004085989A3 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
11/04/2004	WO2004085677A3 Novel markers for inflammatory bowel disease
11/04/2004	WO2004080272A3 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects
11/04/2004	WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004	WO2004074500A3 Method of monitoring genomic instability using 3d microscopy and analysis
11/04/2004	WO2004069194A3 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2004053143A3 Concurrent enzymatic polynucleotide synthesis and detectable signal generation
11/04/2004	WO2004047747A3 Compositions and methods for cell dedifferentiation and tissue regeneration
11/04/2004	WO2004047514A3 Methods for identifying risk of breast cancer and treatments thereof
11/04/2004	WO2004043395A3 Methods and compositions for treating neurological disorders
11/04/2004	WO2004043387A3 Compositions and methods for cancer diagnosis and therapy
11/04/2004	WO2004042030A3 Displacement sandwich immuno-pcr
11/04/2004	WO2004036185A3 Diagnosis and treatment of herpes simplex virus diseases
11/04/2004	WO2004027024A3 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis
11/04/2004	WO2004025251A3 Cell-based detection and differentiation of disease states
11/04/2004	WO2004009540A3 Methods and kits for transferases
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2004003550A3 Individualization of therapy with anticoagulants
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2004001378A3 Methods for protein analyses and protein expression in multicellular organisms and cells therefrom
11/04/2004	WO2003106642A3 Complexity management of genomic dna by locus specific amplication
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003091696A3 Process for identifying and treating specified cell types
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003077851A3 Compounds and methods for analyzing the proteome
11/04/2004	WO2003076593A3 Genomic screen for epigenetically silenced genes associated with cancer
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003058201A3 Methods for identifying marker genes for cancer
11/04/2004	WO2003021226A3 Peptide biomarker and method of identification
11/04/2004	WO2003004696A3 A distributed system for epigenetic based prediction of complex phenotypes
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040220750 Method for identifying matched groups
11/04/2004	US20040220412 Compositions and kits pertaining to analyte determination
11/04/2004	US20040220395 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
11/04/2004	US20040220257 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing said complex to compound such as Spiro [Cyclopentane-1,5'-[5H]Dibenzo [a,d]Cyclohepten]-2-one, 10', 11'-dihydro-3-methylene-
11/04/2004	US20040220127 Methods and compositions relating to 5'-chimeric ribonucleic acids
11/04/2004	US20040220125 Biosynthetic platform for cardioprotective gene expression using immature heart tissue
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	US20040219694 Bioassay comprising immobilized glucose dehydrogenase and/or diaphorase for use in monitoring hygiene of surfaces used in commercial food preparation
11/04/2004	US20040219693 Using labeled neomycin, immobilized on solid support to capture and detect RNA sequences; high-throughput screening
11/04/2004	US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004	US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004	US20040219656 Novel antibacterial and herbicidal compounds and system for screening the same
11/04/2004	US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219628 Microorganism-collecting chip, microorganism-collecting kit, method of quantifying microorganisms, specimen for confirming normal state of microorganism-quantifying apparatus and microorganism-quantifying apparatus
11/04/2004	US20040219627 Methods for measuring bacteria, bacteria measuring apparatuses, and storage media for storing computer-executable programs for analyzing bacteria
11/04/2004	US20040219626 Method for identifying fungicidally active compounds
11/04/2004	US20040219625 Detection method for identifying hydrolases
11/04/2004	US20040219623 Low Density Lipoproteins; Adding to serum a surfactant such as polyoxyethylenealkylene phenyl ethers and polyoxyethylenealkylene tribenzylphenyl ethers and a enzyme to induce reactions; eliminates necessity for pretreatments such as centrifugation and electrophoresis
11/04/2004	US20040219622 Phosphine-containing formulations for chemiluminescent luciferase assays
11/04/2004	US20040219620 Chromogenic substrate with a pH indicator dye
11/04/2004	US20040219618 Identifying micro-organisms
11/04/2004	US20040219617 Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples
11/04/2004	US20040219610 Methods and compositions for diagnosing, preventing, and treating Alzheimer's disease
11/04/2004	US20040219609 Methods for modulating proteins not previously known as proteases
11/04/2004	US20040219600 Using glutathione-s-transferase expression as diagnostic indicator of nervous system disorders and neurotoxicity; immmunoassay;
11/04/2004	US20040219599 Multi-partite ligands and methods of identifying and using same
11/04/2004	US20040219596 Modified carbon nanotubes as molecular labels with application to DNA sequencing

1 ... 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 ... 3003